Abstract
In the last decade, a new surgical treatment modality was developed for frontal secondary headache, based on the assumption that the trigger of this pain entity is the entrapment of peripheral sensory nerves. The surgery entails a procedure, where an endoscopic approach is used to decompress the supraorbital and supratrochlear nerve branches, which are entrapped by the periosteum in the region of the corrugator supercilii muscle. Candidates for the surgery define their headache as moderate to severe persistent daily pressure or tension, localized in the frontal area, sometimes accompanied by symptoms of nausea and photophobia mimicking a primary headache—migraine. We created a step-by-step screening algorithm which is used to differentiate patients that have the highest chance for a successful surgical decompression. Up to now, published data regarding this type of surgery demonstrate long-lasting successful outcomes, while adverse effects are minor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization. Headache disorders. 2012. http://www.who.int/mediacentre/factsheets/fs277/en/. Accessed 11 Sept 2016.
Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000;106:429–34.
Janis JE, Ghavami A, Lemmon JA, Leedy JE, Guyuron B. Anatomy of the corrugator supercilii muscle: part I. corrugator topography. Plast Reconstr Surg. 2007;120:1647–53.
Janis JE, Ghavami A, Lemmon JA, Leedy JE, Guyuron B. The anatomy of the corrugator supercilii muscle: part II. Supraorbital nerve branching patterns. Plast Reconstr Surg. 2008;121:233–40.
Janis JE, Hatef DA, Hagan R, Schaub T, Liu JH, Thakar H, Bolden KM, Heller JB, Kurkjian TJ. Anatomy of the supratrochlear nerve: implications for the surgical treatment of migraine headaches. Plast Reconstr Surg. 2013;131:743–50.
Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg. 2004;114:652–7.
Bearden WH, Anderson RL. Corrugator superciliaris muscle excision for tension and migraine headaches. Ophthal Plast Reconstr Surg. 2005;21:418–22.
de Ru JA, Schellekens PP, Lohuis PJ. Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients. J Neural Transm. 2011;118:1571–4.
Gfrerer L, Maman DY, Tessler O, Austen WG Jr. Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes. Plast Reconstr Surg. 2014;134:771–8.
Edoardo R, Giorgia C. Frontal endoscopic myotomies for chronic headache. J Craniofac Surg. 2015;26:201–3.
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
Filipović B, de Ru JA, van de Langenberg R, Borggreven PA, Lacković Z, Lohuis PJFM. Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review. Eur Arch Otorhinolaryngol. 2017;274:2093–106. https://doi.org/10.1007/s00405-017-4450-x.
Lee M, Monson MA, Liu MT, Reed D, Guyuron B. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg. 2013;131:751–7.
Kung TA, Guyuron B, Cederna PS. Migraine surgery: a plastic surgery solution for refractory migraine headache. Plast Reconstr Surg. 2011;127:181–9.
Liu MT, Armijo BS, Guyuron B. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type a to identify the trigger sites. Plast Reconstr Surg. 2012;129:413–9.
de Ru JA, Buwalda J. Botulinum toxin a injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache. J Laryngol Otol. 2008;123:412–7.
Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des. 2005;11:2671–86.
Blasi J, Chapman ER, Link E, et al. Botulinum neurotoxin a selectively cleaves the synaptic protein SNAP-25. Nature. 1993;365:160–3.
Silberstein SD. The use of Botulinum toxin in the Management of Headache Disorders. Semin Neurol. 2016;36:92–8.
Fallucco M, Janis JE, Hagan RR. The anatomical morphology of the supraorbital notch: clinical relevance to the surgical treatment of migraine headaches. Plast Reconstr Surg. 2012;130:1227–33.
Liu MT, Chim H, Guyuron B. Outcome comparison of endoscopic and transpalpebral decompression for treatment of frontal migraine headaches. Plast Reconstr Surg. 2012;129:1113–9.
Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014;134:131–41.
Chepla KJ, Oh E, Guyuron B. Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache. Plast Reconstr Surg. 2012;129:656–62.
Kurlander DE, Punjabi A, Liu MT, Sattar A, Guyuron B. In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (site II). Plast Reconstr Surg. 2014;133:897–903.
Janis JE, Hatef DA, Reece EM, McCluskey PD, Schaub TA, Guyuron B. Neurovascular compression of the greater occipital nerve: implications for migraine headaches. Plast Reconstr Surg. 2010;126:1996–2001.
Larson K, Lee M, Davis J, Guyuron B. Factors contributing to migraine headache surgery failure and success. Plast Reconstr Surg. 2011;128:1069–75.
Yancey JR, Sheridan R, Koren KG. Chronic daily headache: diagnosis and management. Am Fam Physician. 2014;89:642–8.
Olesen J, Peer Tfelt-Hansen K, Welch A, Goadsby PJ, Ramadan NM. The headaches third edition. Philadelphia: Lippincott Williams and Wilkins; 2006.
Villalón CM, Centurión D, Valdivia LF, de Vries P, Saxena PR. Migraine: pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol. 2003;1:71–4.
Filipovic B, de Ru JA, Hakim S, van de Langenberg R, Borggreven PA, Lohuis PJFM. Treatment of frontal secondary headache attributed to Supratrochlear and supraorbital nerve entrapment with Oral medication or Botulinum toxin type a vs endoscopic decompression surgery. JAMA Facial Plast Surg. 2018 Sep 1;20(5):394–400. https://doi.org/10.1001/jamafacial.2018.0268.
Omranifard M, Abdali H, Ardakani MR, Talebianfar M. a comparison of outcome of medical and surgical treatment of migraine headache: in 1 year follow-up. Adv Biomed Res. 2016;29(5):121.
Diener HC, Dodick DW, Aurora SK, al E. PREEMPT 2 chronic migraine study group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–14.
Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012;307:1736–45.
Gady J, Ferneini EM. Botulinum toxin a and headache treatment. Conn Med. 2013;77:165–6.
Morra ME, Elgebaly A, Elmaraezy A, et al. therapeutic efficacy and safety of Botulinum toxin a therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17:63.
Matak, I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 2014;119–120:39–59.
Lacković Z, Filipović B, Matak I, Helyes Z. Activity of botulinum toxin type a in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol. 2016;173:279–91.
Filipović B, Matak I, Lacković Z. Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region. J Neural Transm. 2014;121:555–63.
Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000;53:786–92.
Freeman TB, Vawter DE, Leaverton PE, al E. use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson’s disease. N Engl J Med. 1999;341:988–92.
Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain. 2012;13:361–78.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Filipović, B., de Ru, J.A., Lohuis, P.J.F.M. (2020). Decompression Endoscopic Surgery for Frontal Secondary Headache Attributed to Supraorbital and Supratrochlear Nerve Entrapment: The Utrecht Experience. In: Raposio, E. (eds) Atlas of Surgical Therapy for Migraine and Tension-Type Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-29505-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-29505-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29504-2
Online ISBN: 978-3-030-29505-9
eBook Packages: MedicineMedicine (R0)